UPDATED Apr 17, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €340.00 | -3.7% | -2.0% | €20.2b | €439.38 | PS17x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
DIE | €203.00 | -1.4% | 21.0% | €10.7b | €246.00 | PE21.5x | E25.2% | 1.8% | Retail | ||
UCB | €119.90 | 2.0% | 37.6% | €22.8b | €122.18 | PE66.3x | E25.2% | 1.1% | Pharmaceuticals & Biotech |